Galvus Met (Vidagliptin/Metformin) is a combination of two active ingredients both of which are used to control and treat patients suffering from type 2 diabetes. The active ingredient known as metformin works by reducing sugar production by the liver while simultaneously increasing the body’s sensitivity to insulin. The other active ingredient (Vidagliptin) is in a class of drugs called DPP-4 inhibitors. It helps the body to produce more insulin (required to control blood sugar) and also reduces the production of a certain hormone (glucagon). Decreasing glucagon production helps to lower glucose levels in the patient’s blood.